[Colon cancer: molecular markers]

Dtsch Med Wochenschr. 2005 Apr 8;130(14):880-2. doi: 10.1055/s-2005-865102.
[Article in German]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Biomarkers, Tumor / genetics
  • Camptothecin / analogs & derivatives*
  • Camptothecin / therapeutic use
  • Clinical Trials as Topic
  • Colorectal Neoplasms / diagnosis
  • Colorectal Neoplasms / drug therapy
  • Colorectal Neoplasms / etiology
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / mortality
  • Colorectal Neoplasms / prevention & control
  • DNA Repair
  • DNA, Neoplasm / analysis
  • Feces / chemistry
  • Fluorouracil / therapeutic use
  • Genes, Tumor Suppressor
  • Genes, ras
  • Genetic Markers
  • Humans
  • Irinotecan
  • Microsatellite Repeats
  • Mutation
  • Oncogenes
  • Polymerase Chain Reaction
  • Prognosis
  • Prospective Studies
  • Sensitivity and Specificity
  • Treatment Outcome
  • Tumor Cells, Cultured

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents, Phytogenic
  • Biomarkers, Tumor
  • DNA, Neoplasm
  • Genetic Markers
  • Irinotecan
  • Fluorouracil
  • Camptothecin